128 related articles for article (PubMed ID: 27203214)
1. Down-regulation of tensin2 enhances tumorigenicity and is associated with a variety of cancers.
Hong SY; Shih YP; Sun P; Hsieh WJ; Lin WC; Lo SH
Oncotarget; 2016 Jun; 7(25):38143-38153. PubMed ID: 27203214
[TBL] [Abstract][Full Text] [Related]
2. AXL phosphorylates and up-regulates TNS2 and its implications in IRS-1-associated metabolism in cancer cells.
Cheng LC; Chen YL; Cheng AN; Lee AY; Cho CY; Huang JS; Chuang SE
J Biomed Sci; 2018 Nov; 25(1):80. PubMed ID: 30419905
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the Tensin2 SH2-PTB domain, but not the loss of its PTPase activity, induces podocyte injury in FVB/N mouse strain.
Sasaki H; Takahashi Y; Ogawa T; Hiura K; Nakano K; Sugiyama M; Okamura T; Sasaki N
Exp Anim; 2020 Apr; 69(2):135-143. PubMed ID: 31723089
[TBL] [Abstract][Full Text] [Related]
4. Genetic background-dependent diversity in renal failure caused by the tensin2 gene deficiency in the mouse.
Sasaki H; Marusugi K; Kimura J; Kitamura H; Nagasaki K; Torigoe D; Agui T; Sasaki N
Biomed Res; 2015; 36(5):323-30. PubMed ID: 26522149
[TBL] [Abstract][Full Text] [Related]
5. C-terminal tensin-like (CTEN): a promising biomarker and target for cancer.
Lo SH
Int J Biochem Cell Biol; 2014 Jun; 51():150-4. PubMed ID: 24735711
[TBL] [Abstract][Full Text] [Related]
6. Tensins - emerging insights into their domain functions, biological roles and disease relevance.
Liao YC; Lo SH
J Cell Sci; 2021 Feb; 134(4):. PubMed ID: 33597154
[TBL] [Abstract][Full Text] [Related]
7. Functional validation of tensin2 SH2-PTB domain by CRISPR/Cas9-mediated genome editing.
Marusugi K; Nakano K; Sasaki H; Kimura J; Yanobu-Takanashi R; Okamura T; Sasaki N
J Vet Med Sci; 2016 Oct; 78(9):1413-1420. PubMed ID: 27246398
[TBL] [Abstract][Full Text] [Related]
8. Tensin2-deficient mice on FVB/N background develop severe glomerular disease.
Uchio-Yamada K; Monobe Y; Akagi K; Yamamoto Y; Ogura A; Manabe N
J Vet Med Sci; 2016 Jun; 78(5):811-8. PubMed ID: 26854109
[TBL] [Abstract][Full Text] [Related]
9. Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.
Hafizi S; Sernstad E; Swinny JD; Gomez MF; Dahlbäck B
Int J Biochem Cell Biol; 2010 Jan; 42(1):52-61. PubMed ID: 19747564
[TBL] [Abstract][Full Text] [Related]
10. Distinct distribution of the tensin family in the mouse kidney and small intestine.
Nishino T; Sasaki N; Chihara M; Nagasaki K; Torigoe D; Kon Y; Agui T
Exp Anim; 2012; 61(5):525-32. PubMed ID: 23095816
[TBL] [Abstract][Full Text] [Related]
11. Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration.
Chen H; Duncan IC; Bozorgchami H; Lo SH
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):733-8. PubMed ID: 11792844
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Analysis of the Expression of Adhesion Proteins: TNS1, TNS2 and TNS3 in Correlation with Clinicopathological Parameters in Gastric Cancer.
Nizioł M; Zińczuk J; Zaręba K; Guzińska-Ustymowicz K; Pryczynicz A
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33926026
[TBL] [Abstract][Full Text] [Related]
13. Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.
Yam JW; Ko FC; Chan CY; Yau TO; Tung EK; Leung TH; Jin DY; Ng IO
Hepatology; 2006 Oct; 44(4):881-90. PubMed ID: 17006924
[TBL] [Abstract][Full Text] [Related]
14. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
[TBL] [Abstract][Full Text] [Related]
15.
Martínez-Abarca Millán A; Soler Beatty J; Valencia Expósito A; Martín-Bermudo MD
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510408
[TBL] [Abstract][Full Text] [Related]
16. START-GAP2/DLC2 is localized in focal adhesions via its N-terminal region.
Kawai K; Seike J; Iino T; Kiyota M; Iwamae Y; Nishitani H; Yagisawa H
Biochem Biophys Res Commun; 2009 Mar; 380(4):736-41. PubMed ID: 19250640
[TBL] [Abstract][Full Text] [Related]
17. The molecular and clinical role of Tensin 1/2/3 in cancer.
Mainsiouw L; Ryan ME; Hafizi S; Fleming JC
J Cell Mol Med; 2023 Jul; 27(13):1763-1774. PubMed ID: 37296531
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tensin-promoted cell migration by its focal adhesion binding and Src homology domain 2.
Chen H; Lo SH
Biochem J; 2003 Mar; 370(Pt 3):1039-45. PubMed ID: 12495434
[TBL] [Abstract][Full Text] [Related]
19. Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma.
Chan LK; Chiu YT; Sze KM; Ng IO
Oncotarget; 2015 Aug; 6(25):20964-76. PubMed ID: 26035355
[TBL] [Abstract][Full Text] [Related]
20. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.
Lo SH; Lo TB
Cancer Res; 2002 Aug; 62(15):4217-21. PubMed ID: 12154022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
